Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Amphastar Pharmaceuticals stock | $18.92

Learn how to easily invest in Amphastar Pharmaceuticals stock.

Amphastar Pharmaceuticals Inc is a drug manufacturers-specialty & generic business based in the US. Amphastar Pharmaceuticals shares (AMPH) are listed on the NASDAQ and all prices are listed in US Dollars. Amphastar Pharmaceuticals employs 1,980 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Amphastar Pharmaceuticals

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AMPH – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Amphastar Pharmaceuticals stock price (NASDAQ: AMPH)

Use our graph to track the performance of AMPH stocks over time.

Amphastar Pharmaceuticals shares at a glance

Information last updated 2021-10-23.
Latest market close$18.92
52-week range$16.91 - $21.44
50-day moving average $18.86
200-day moving average $19.24
Wall St. target price$22.75
PE ratio 90.9479
Dividend yield N/A (0%)
Earnings per share (TTM) $0.21

Buy Amphastar Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Amphastar Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Amphastar Pharmaceuticals price performance over time

Historical closes compared with the close of $18.92 from 2021-10-26

1 week (2021-10-20) -2.72%
1 month (2021-09-27) -1.77%
3 months (2021-07-27) -8.99%
6 months (2021-04-27) 10.26%
1 year (2020-10-27) -4.83%
2 years (2019-10-25) -3.07%
3 years (2018-10-26) 3.44%
5 years (2016-10-27) 2.83%

Is Amphastar Pharmaceuticals under- or over-valued?

Valuing Amphastar Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amphastar Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Amphastar Pharmaceuticals's P/E ratio

Amphastar Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 91x. In other words, Amphastar Pharmaceuticals shares trade at around 91x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Amphastar Pharmaceuticals's PEG ratio

Amphastar Pharmaceuticals's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.77. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Amphastar Pharmaceuticals's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Amphastar Pharmaceuticals's EBITDA

Amphastar Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $55.7 million.

The EBITDA is a measure of a Amphastar Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.

Amphastar Pharmaceuticals financials

Revenue TTM $384 million
Operating margin TTM 8.38%
Gross profit TTM $143.3 million
Return on assets TTM 3.18%
Return on equity TTM 2.55%
Profit margin 2.72%
Book value $8.80
Market capitalisation $921.7 million

TTM: trailing 12 months

Shorting Amphastar Pharmaceuticals shares

There are currently 2.3 million Amphastar Pharmaceuticals shares held short by investors – that's known as Amphastar Pharmaceuticals's "short interest". This figure is 5.5% down from 2.4 million last month.

There are a few different ways that this level of interest in shorting Amphastar Pharmaceuticals shares can be evaluated.

Amphastar Pharmaceuticals's "short interest ratio" (SIR)

Amphastar Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Amphastar Pharmaceuticals shares currently shorted divided by the average quantity of Amphastar Pharmaceuticals shares traded daily (recently around 159428.49162011). Amphastar Pharmaceuticals's SIR currently stands at 14.32. In other words for every 100,000 Amphastar Pharmaceuticals shares traded daily on the market, roughly 14320 shares are currently held short.

However Amphastar Pharmaceuticals's short interest can also be evaluated against the total number of Amphastar Pharmaceuticals shares, or, against the total number of tradable Amphastar Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Amphastar Pharmaceuticals's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Amphastar Pharmaceuticals shares in existence, roughly 50 shares are currently held short) or 0.0584% of the tradable shares (for every 100,000 tradable Amphastar Pharmaceuticals shares, roughly 58 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Amphastar Pharmaceuticals.

Find out more about how you can short Amphastar Pharmaceuticals stock.

Amphastar Pharmaceuticals share dividends

We're not expecting Amphastar Pharmaceuticals to pay a dividend over the next 12 months.

Amphastar Pharmaceuticals share price volatility

Over the last 12 months, Amphastar Pharmaceuticals's shares have ranged in value from as little as $16.91 up to $21.44. A popular way to gauge a stock's volatility is its "beta".

AMPH.US volatility(beta: 0.74)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amphastar Pharmaceuticals's is 0.736. This would suggest that Amphastar Pharmaceuticals's shares are less volatile than average (for this exchange).

Amphastar Pharmaceuticals overview

Amphastar Pharmaceuticals, Inc. , a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers procainamide for documented ventricular arrhythmias; neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; medroxyprogesterone acetate injectable suspension for the prevention of pregnancy; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block, as well as manufactures and distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices.

Frequently asked questions

What percentage of Amphastar Pharmaceuticals is owned by insiders or institutions?
Currently 23.398% of Amphastar Pharmaceuticals shares are held by insiders and 57.9% by institutions.
How many people work for Amphastar Pharmaceuticals?
Latest data suggests 1,980 work at Amphastar Pharmaceuticals.
When does the fiscal year end for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals's fiscal year ends in December.
Where is Amphastar Pharmaceuticals based?
Amphastar Pharmaceuticals's address is: 11570 6th Street, Rancho Cucamonga, CA, United States, 91730
What is Amphastar Pharmaceuticals's ISIN number?
Amphastar Pharmaceuticals's international securities identification number is: US03209R1032
What is Amphastar Pharmaceuticals's CUSIP number?
Amphastar Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 03209R103

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site